Illumina s Q4 Revenues Surge on Strong Sales, Net Losses Narrow | GenomeWeb

NEW YORK, Jan. 27 (GenomeWeb News) - Illumina today reported a 176 percent increase in revenues for its fourth fiscal quarter, accompanied by diminishing net losses and a slight decrease in R&D spending.

For the quarter ended Dec. 28, 2003, Illumina reported revenue of $10.7 million, compared to $3.9 million for the fourth quarter of 2002.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.